NTRK Gene Fusion Testing: FastTrk Update
FastTRK is a clinical testing program for the diagnosis of NTRK gene fusions. Sponsored by Bayer, this is a complimentary service for clinicians to determine whether their patients’ cancer has an NTRK gene fusion.
Eligibility criteria includes ALL patients with solid tumours that are metastatic or ...